What We Do
Most life sciences organisations approach commercialisation as a series of sequential activities. Positioning happens first, then launch planning, then marketing activation, often with little continuity between them. GTM+ is built on a different premise: that commercial success depends on the integrity of the connections between these phases, not just the quality of each one in isolation. The framework spans five integrated phases. Market opportunity assessment establishes the commercial context, mapping competitive dynamics, stakeholder needs, and category readiness. Positioning and messaging architecture translates that intelligence into a clear value framework that works across audience segments, from clinicians and payers to investors and procurement leaders. Launch readiness planning stress-tests organisational preparedness across marketing, sales enablement, and channel strategy before commitments are made. KOL and partner identification maps the influence networks most relevant to commercial uptake. Integrated marketing activation coordinates the programs that sustain momentum once the market has been entered.
Services Offered
Early-stage organizations preparing for a first commercial launch have different requirements than established firms entering new indications or geographies, and the framework is structured to reflect that.
